An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles.


Journal

Nature nanotechnology
ISSN: 1748-3395
Titre abrégé: Nat Nanotechnol
Pays: England
ID NLM: 101283273

Informations de publication

Date de publication:
08 2021
Historique:
received: 22 01 2021
accepted: 27 04 2021
pubmed: 5 6 2021
medline: 28 8 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Minimizing the spread of viruses in the environment is the first defence line when fighting outbreaks and pandemics, but the current COVID-19 pandemic demonstrates how difficult this is on a global scale, particularly in a sustainable and environmentally friendly way. Here we introduce and develop a sustainable and biodegradable antiviral filtration membrane composed of amyloid nanofibrils made from food-grade milk proteins and iron oxyhydroxide nanoparticles synthesized in situ from iron salts by simple pH tuning. Thus, all the membrane components are made of environmentally friendly, non-toxic and widely available materials. The membrane has outstanding efficacy against a broad range of viruses, which include enveloped, non-enveloped, airborne and waterborne viruses, such as SARS-CoV-2, H1N1 (the influenza A virus strain responsible for the swine flu pandemic in 2009) and enterovirus 71 (a non-enveloped virus resistant to harsh conditions, such as highly acidic pH), which highlights a possible role in fighting the current and future viral outbreaks and pandemics.

Identifiants

pubmed: 34083772
doi: 10.1038/s41565-021-00920-5
pii: 10.1038/s41565-021-00920-5
doi:

Substances chimiques

Amyloid 0
Antiviral Agents 0
Ferric Compounds 0
Lactoglobulins 0
ferric hydroxide 2UA751211N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

918-925

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Liu, C. et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent. Sci. 6, 315–331 (2020).
doi: 10.1021/acscentsci.0c00272
Gall, A. M., Mariñas, B. J., Lu, Y. & Shisler, J. L. Waterborne viruses: a barrier to safe drinking water. PLoS Pathog. 11, 1–7 (2015).
doi: 10.1371/journal.ppat.1004867
Reynolds, K. A., Mena, K. D. & Gerba, C. Risk of waterborne illness via drinking water in the United States. Rev. Environ. Contam. Toxicol. 192, 117–158 (2008).
doi: 10.1007/978-0-387-71724-1_4
Sinclair, R. G., Jones, E. L. & Gerba, C. P. Viruses in recreational water-borne disease outbreaks: a review. J. Appl. Microbiol. 107, 1769–1780 (2009).
doi: 10.1111/j.1365-2672.2009.04367.x
Sorrell, E. M., Wan, H., Araya, Y., Song, H. & Perez, D. R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl Acad. Sci. USA 106, 7565–7570 (2009).
doi: 10.1073/pnas.0900877106
Morawska, L. & Cao, J. Airborne transmission of SARS-CoV-2: the world should face the reality. Environ. Int. 139, 105730 (2020).
doi: 10.1016/j.envint.2020.105730
Leung, N. H. L. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 26, 676–680 (2020).
doi: 10.1038/s41591-020-0843-2
Prather, K. A. et al. Airborne transmission of SARS-CoV-2. Science 370, 303–305 (2020).
Tellier, R. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 12, 1657–1662 (2006).
doi: 10.3201/eid1211.060426
Patrício Silva, A. L. et al. Increased plastic pollution due to COVID-19 pandemic: challenges and recommendations. Chem. Eng. J. 405, 126683 (2021).
doi: 10.1016/j.cej.2020.126683
Ammendolia, J., Saturno, J., Brooks, A. L., Jacobs, S. & Jambeck, J. R. An emerging source of plastic pollution: environmental presence of plastic personal protective equipment (PPE) debris related to COVID-19 in a metropolitan city. Environ. Pollut. 269, 116160 (2021).
doi: 10.1016/j.envpol.2020.116160
Prata, J. C., Silva, A. L. P., Walker, T. R., Duarte, A. C. & Rocha-Santos, T. COVID-19 pandemic repercussions on the use and management of plastics. Environ. Sci. Technol. 54, 7760–7765 (2020).
doi: 10.1021/acs.est.0c02178
Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020).
doi: 10.1038/s41586-020-2798-3
Ball, P. The lightning-fast quest for COVID vaccines—and what it means for other diseases. Nature 589, 16–18 (2021).
doi: 10.1038/d41586-020-03626-1
Khamsi, R. Can the world make enough coronavirus vaccine? Nature 580, 578–580 (2020).
doi: 10.1038/d41586-020-01063-8
Korber, B. et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812–827 (2020).
doi: 10.1016/j.cell.2020.06.043
Weisblum, Y. et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 9, e61312 (2020).
doi: 10.7554/eLife.61312
Boone, S. A. & Gerba, C. P. Significance of fomites in the spread of respiratory and enteric viral disease. Appl. Environ. Microbiol. 73, 1687–1696 (2007).
doi: 10.1128/AEM.02051-06
Tuladhar, E. et al. Reducing viral contamination from finger pads: handwashing is more effective than alcohol-based hand disinfectants. J. Hosp. Infect. 90, 226–234 (2015).
doi: 10.1016/j.jhin.2015.02.019
Coia, J. E. et al. Guidance on the use of respiratory and facial protection equipment. J. Hosp. Infect. 85, 170–182 (2013).
doi: 10.1016/j.jhin.2013.06.020
Sangkham, S. Face mask and medical waste disposal during the novel COVID-19 pandemic in Asia. Case Stud. Chem. Environ. Eng. 2, 100052 (2020).
doi: 10.1016/j.cscee.2020.100052
Tran, H. N. et al. SARS-CoV-2 coronavirus in water and wastewater: a critical review about presence and concern. Environ. Res. 193, 110265 (2021).
doi: 10.1016/j.envres.2020.110265
Drinking-water: Key Facts (World Health Organization, 2019); https://www.who.int/news-room/fact-sheets/detail/drinking-water
Ramani, S. & Kang, G. Viruses causing childhood diarrhoea in the developing world. Curr. Opin. Infect. Dis. 22, 477–482 (2009).
doi: 10.1097/QCO.0b013e328330662f
Prevost, B. et al. Viral persistence in surface and drinking water: suitability of PCR pre-treatment with intercalating dyes. Water Res. 91, 68–76 (2016).
doi: 10.1016/j.watres.2015.12.049
Carratalà, A., Bachmann, V., Julian, T. R. & Kohn, T. Adaptation of human enterovirus to warm environments leads to resistance against chlorine disinfection. Environ. Sci. Technol. 54, 11292–11300 (2020).
doi: 10.1021/acs.est.0c03199
Sigstam, T. et al. Subtle differences in virus composition affect disinfection kinetics and mechanisms. Appl. Environ. Microbiol. 79, 3455–3467 (2013).
doi: 10.1128/AEM.00663-13
Wigginton, K. R., Ye, Y. & Ellenberg, R. M. Emerging investigators series: the source and fate of pandemic viruses in the urban water cycle. Environ. Sci. Water Res. Technol. 1, 735–746 (2015).
doi: 10.1039/C5EW00125K
Bogler, A. et al. Rethinking wastewater risks and monitoring in light of the COVID-19 pandemic. Nat. Sustain. 3, 981–990 (2020).
doi: 10.1038/s41893-020-00605-2
Bivins, A. et al. Persistence of SARS-CoV-2 in water and wastewater. Environ. Sci. Technol. Lett. 7, 937–942 (2020).
doi: 10.1021/acs.estlett.0c00730
Hornstra, L. M. et al. Monitoring the integrity of reverse osmosis membranes using novel indigenous freshwater viruses and bacteriophages. Environ. Sci. Water Res. Technol. 5, 1535–1544 (2019).
doi: 10.1039/C9EW00318E
Ale, A. et al. Exposure to a nanosilver-enabled consumer product results in similar accumulation and toxicity of silver nanoparticles in the marine mussel Mytilus galloprovincialis. Aquat. Toxicol. 211, 46–56 (2019).
doi: 10.1016/j.aquatox.2019.03.018
Abramenko, N. et al. The effect of capping agents on the toxicity of silver nanoparticles to Danio rerio embryos. Nanotoxicology 13, 1–13 (2019).
doi: 10.1080/17435390.2018.1498931
Aquino De Carvalho, N., Stachler, E. N., Cimabue, N. & Bibby, K. Evaluation of Phi6 persistence and suitability as an enveloped virus surrogate. Environ. Sci. Technol. 51, 8692–8700 (2017).
doi: 10.1021/acs.est.7b01296
Farley, M. M. 2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century. Am. J. Med. Sci. 340, 202–208 (2010).
doi: 10.1097/MAJ.0b013e3181e937b0
Pecson, B. M., Decrey, L. & Kohn, T. Photoinactivation of virus on iron-oxide coated sand: enhancing inactivation in sunlit waters. Water Res. 46, 1763–1770 (2012).
doi: 10.1016/j.watres.2011.12.059
Block, K. A. et al. Disassembly of the cystovirus Φ6 envelope by montmorillonite clay. MicrobiologyOpen 3, 42–51 (2014).
doi: 10.1002/mbo3.148
Kosmulski, M. Isoelectric points and points of zero charge of metal (hydr)oxides: 50 years after Parks’ review. Adv. Colloid Interface Sci. 238, 1–61 (2016).
doi: 10.1016/j.cis.2016.10.005
Michen, B. & Graule, T. Isoelectric points of viruses. J. Appl. Microbiol. 109, 388–397 (2010).
doi: 10.1111/j.1365-2672.2010.04663.x
Nieto-Juarez, J. I. & Kohn, T. Virus removal and inactivation by iron (hydr)oxide-mediated Fenton-like processes under sunlight and in the dark. Photochem. Photobiol. Sci. 12, 1596–1605 (2013).
doi: 10.1039/c3pp25314g
Ryan, J. N. et al. Field and laboratory investigations of inactivation of viruses (PRD1 and MS2) attached to iron oxide-coated quartz sand. Environ. Sci. Technol. 36, 2403–2413 (2002).
doi: 10.1021/es011285y
Harvey, R. W. & Ryan, J. N. Use of PRD1 bacteriophage in groundwater viral transport, inactivation, and attachment studies. FEMS Microbiol. Ecol. 49, 3–16 (2004).
doi: 10.1016/j.femsec.2003.09.015
Vajda, J. et al. Mono- and polyprotic buffer systems in anion exchange chromatography of influenza virus particles. J. Chromatogr. A 1448, 73–80 (2016).
doi: 10.1016/j.chroma.2016.04.047
Pandey, L. M. Surface engineering of personal protective equipments (PPEs) to prevent the contagious infections of SARS-CoV-2. Surf. Eng. 36, 901–907 (2020).
doi: 10.1080/02670844.2020.1801034
Shirasaki, N., Matsushita, T., Matsui, Y., Marubayashi, T. & Murai, K. Investigation of enteric adenovirus and poliovirus removal by coagulation processes and suitability of bacteriophages MS2 and φX174 as surrogates for those viruses. Sci. Total Environ. 563–564, 29–39 (2016).
doi: 10.1016/j.scitotenv.2016.04.090
Shokri Doodeji, M. & Zerafat, M. A review on the applications of nanofiltration in virus removal and pharmaceutical industries. Glob. J. Nanomed. 3, 1–3 (2018).
Bolisetty, S., Peydayesh, M. & Mezzenga, R. Sustainable technologies for water purification from heavy metals: review and analysis. Chem. Soc. Rev. 48, 463–487 (2019).
doi: 10.1039/C8CS00493E
Muga, H. E. & Mihelcic, J. R. Sustainability of wastewater treatment technologies. J. Environ. Manag. 88, 437–447 (2008).
doi: 10.1016/j.jenvman.2007.03.008
Razali, M. et al. Sustainable wastewater treatment and recycling in membrane manufacturing. Green Chem. 17, 5196–5205 (2015).
doi: 10.1039/C5GC01937K
Szekely, G., Jimenez-Solomon, M. F., Marchetti, P., Kim, J. F. & Livingston, A. G. Sustainability assessment of organic solvent nanofiltration: from fabrication to application. Green Chem. 16, 4440–4473 (2014).
doi: 10.1039/C4GC00701H
ViralZone (Swiss Institute of Bioinformatics); www.expasy.org/viralzone
Kurpiewska, K. et al. Investigation of high pressure effect on the structure and adsorption of β-lactoglobulin. Colloids Surf. B 161, 387–393 (2018).
doi: 10.1016/j.colsurfb.2017.10.069
Berman, H. M. et al. The protein data bank. Acta Crystallogr. D 58, 899–907 (2002).
doi: 10.1107/S0907444902003451
Busnadiego, I. et al. Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2. MBio 11, 1–10 (2020).
doi: 10.1128/mBio.01928-20
Pohl, M. O. et al. SARS-CoV-2 variants reveal features critical for replication in primary human cells. PLoS Biol. 19, e3001006 (2021).
doi: 10.1371/journal.pbio.3001006
Jung, J. M., Savin, G., Pouzot, M., Schmitt, C. & Mezzenga, R. Structure of heat-induced β-lactoglobulin aggregates and their complexes with sodium-dodecyl sulfate. Biomacromolecules 9, 2477–2486 (2008).
doi: 10.1021/bm800502j

Auteurs

Archana Palika (A)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Antonius Armanious (A)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Akram Rahimi (A)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
BluAct Technologies GmbH, Zurich, Switzerland.

Chiara Medaglia (C)

Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.

Matteo Gasbarri (M)

Institute of Materials, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Stephan Handschin (S)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Antonella Rossi (A)

Department of Chemical and Geological Science, University of Cagliari, Cagliari, Italy.
Department of Materials, ETH Zurich, Zurich, Switzerland.

Marie O Pohl (MO)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Idoia Busnadiego (I)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Christian Gübeli (C)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Ravi B Anjanappa (RB)

Department of Biology, ETH Zurich, Zurich, Switzerland.

Sreenath Bolisetty (S)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
BluAct Technologies GmbH, Zurich, Switzerland.

Mohammad Peydayesh (M)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Silke Stertz (S)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Benjamin G Hale (BG)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Caroline Tapparel (C)

Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.

Francesco Stellacci (F)

Institute of Materials, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Department of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Raffaele Mezzenga (R)

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. raffaele.mezzenga@hest.ethz.ch.
Department of Materials, ETH Zurich, Zurich, Switzerland. raffaele.mezzenga@hest.ethz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH